发明名称 |
Screening Methods for Transfusion Related Acute Lung Injury (TRALI) |
摘要 |
The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation |
申请公布号 |
US2015203915(A1) |
申请公布日期 |
2015.07.23 |
申请号 |
US201514678827 |
申请日期 |
2015.04.03 |
申请人 |
ERNST-MORITZ-ARNDT-UNIVERSITÄT GREIFSWALD ;DRK BLUTSPENDEDIENST WEST GMBH |
发明人 |
Greinacher Andreas;Wesche Jan;Bux Juergen;Reil Angelika |
分类号 |
C12Q1/68;C07K14/47;G01N33/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of determining whether a donor tissue intended for transplant or transfusion will induce transfusion related acute lung injury (TRALI) or graft versus host disease (GVHD) in a human recipient wherein the human recipient expresses the HNA-3a antigen comprising
a) obtaining a sample of the tissue intended for transplant or transfusion in the human subject, b) contacting the sample with a polypeptide comprising the amino acid sequence of SEQ ID NO: 1 or an antigenic fragment thereof to form a complex with HNA-3a specific antibodies in the sample, and c) detecting the complex, wherein the presence of the complex indicates that the donor tissue is likely to induce TRALI or GVHD in a human recipient that expresses the HNA-3a antigen. |
地址 |
Greifswald DE |